Imerys has entered into exclusive negotiations with Syntagma Capital for the potential sale of most of its assets producing kaolin, ground calcium carbonate (“GCC”), precipitated calcium carbonate (“PCC”) and talc, which primarily serve the paper markets for an enterprise value of Euro 390 million including an earn out depending on the future performance of the business.
These activities are operated by approximately 950 employees in 24 plants in the Americas and Asia, as well as certain locations in Europe.
Syntagma Capital is an investment firm based in Brussels, Belgium, which invests in materials, chemicals, industrials, and B2B services sectors.
The closing of the transaction is expected in the course of 2023. The transaction remains subject to the fulfillment of customary conditions for this type of transaction, including the information and consultation of works councils and other regulatory approvals.
Imerys is the world’s leading supplier of mineral-based specialty solutions.
